IonQ (IONQ) announced results of a collaborative research program between IonQ, AstraZeneca (AZN), Amazon Web Services (AMZN), and Nvidia (NVDA) to develop and demonstrate a quantum-accelerated computational chemistry workflow. The results of the collaboration will be showcased at the ISC High Performance conference, which takes place on June 10-13 in Hamburg, Germany. IonQ and its partners demonstrated a large-scale, end-to-end simulation of a Suzuki-Miyaura reaction. The hybrid quantum-classical workflow – orchestrated via Cuda-Q on Amazon Braket, accelerated with Nvidia H200 GPUs through AWS ParallelCluster – delivered more than a 20x speedup in time-to-solution compared to prior benchmarks. This advancement highlights the scalability of IonQ’s quantum systems and their practical potential in pharmaceutical R&D.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IONQ:
- IonQ to Acquire Oxford Ionics for $1.075 Billion
- IonQ to acquire Oxford Ionics in $1.075B transaction
- Grayscale Files for Quantum Computing ETF—A New Gateway for Investors to Tap the Next Big Tech Disruption
- Is IonQ Stock (IONQ) a Buy Now? Technical Indicators Suggest Yes
- IonQ Completes Acquisition of Lightsynq Technologies